¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2021 Ãá°èÇмú´ëȸ : 2021-04-10

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2021 Ãá°èÇмú´ëȸ : 2021-04-10
±³À°ÀÏÀÚ : 2021-04-10
±³À°Àå¼Ò : ÀÓÇǸ®¾óÆÓ¸®½º È£ÅÚ ¼­¿ï  
±³À°ÁÖÁ¦ : ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2021 Ãá°èÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇÑÆÄŲ½¼º´¹×ÀÌ»ó¿îµ¿ÁúȯÇÐȸ
´ã´çÀÚ : ±è½Ã¿ø
¿¬¶ôó : 02-6395-2876  
À̸ÞÀÏ : movement@kmds.or.kr      
±³À°Á¾·ù : ½Å°æ°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í Á¤È¸¿ø 30,000¿ø / ÁØȸ¿ø 20,000¿ø / ºñȸ¿ø 40,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 09:00~09:40 alpha-synuclein pathology in the skin  Charles Adler(Mayo Clinic, USA) 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 09:40~10:10 Neuromodulation in PD and neurodegnerative diseases  ¿ÀÀÀ¼®(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 10:10~10:40 Recent clinical trials in PD: positive and negative  Ãµ»ó¸í(µ¿¾ÆÀÇ´ë) 
È޽Ġ04-10  10:40~10:50 È޽Ġ () 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 10:50~11:20 The link between two pathogenic mechanisms: synucleinopathy and inflammation in PD  ±è¿µÀº(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 11:20~11:50 GBA, lysosome and PD  Ç㿵Àº(Â÷ÀÇ°úÇдë) 
È޽Ġ04-10  11:50~12:00 È޽Ġ () 
±âŸ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 12:00~13:00 ÃÑȸ ¹× Á¡½É½Ä»ç  ±Çµµ¿µ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 13:00~13:30 Autonomic dysfunction in PD: pathophysiology and management  ¿ÀÀ±»ó(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 13:30~14:00 Update in medical treatment for PD  ÀÌÁöÀº(±¹¹Î°Ç°­º¸Çè°ø´ÜÀϻ꺴¿ø) 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 14:00~14:30 Iron-sensitive MRI in parkinsonism  ÀÌÀçÇõ(ºÎ»êÀÇ´ë) 
È޽Ġ04-10  14:30~14:40 È޽Ġ () 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 14:40~15:10 iRBD and syncleinopathy  ÀÌÁö¿µ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 15:10~15:40 Rare genetic disorders with parkinsonism  Àå¿ì¿µ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 04-10 ¸Þ±×·¹Ã÷¾Ë¸®¿ÀÃ÷ 15:40~16:20 Heterogeneity of PD  Robert de Bie(Amsterdam UMC) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2021 Ãá°èÇмú´ëȸ : 2021-04-10""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ Æó·ÅÈ£Èí±â¿¬±¸È¸-Áúº´°ü¸®Ã» ÈÄ¿ø½ÉÆ÷Áö¿ò : 2021-04-10
´ÙÀ½±Û Á¶¼±´ëÇб³º´¿ø 2021 ´ëÇѼºÇü¿Ü°úÇÐȸ ±¤ÁÖÀü³²Áöȸ Ãß°èÇÐȸ : 2021-04-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20835 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ 2024³â Á¦ 1ȸ ³»½Ã°æ Áý´ãȸ : 2024-06-21 0 4 2024-05-27
20834 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ)¾È°ú ±Ý¿äÁý´ãȸ : 2024-06-21 0 0 2024-05-27
20833 ¼­¿ï ´ëÇѳúÀüÁõÇÐȸ 29rd KOREAN EPILEPSY CONGRESS (2024 KEC) 1ÀÏÂ÷ : 2024-06-21 0 0 2024-05-27
20832 ¼­¿ï Á¦8Â÷ µµºÀ±¸ÀÇ»çȸ Çмú¼¼¹Ì³ª(½ÉÇ÷°üÁúȯ ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·á, ºÒ¸éÁõ, Ä¡¸Å¾à¹°Ä¡·á, Ç×Ç÷ÀüÁ¦) : 2024-06-21 0 0 2024-05-27
20831 ºÎ»ê 2024³âµµ ºÎ»ê․°æ³²Áö¿ª ÀÇ°ú´ëÇÐ ½ÅÀÓ±³¼ö ¿öÅ©¼ó (2ÀÏÂ÷) : 2024-06-21 0 1 2024-05-27
20830 Á¦ÁÖ ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-06-21 0 0 2024-05-27
20829 ¼­¿ï 2024³â °áÇÙ°ü¸®±³À° 2±â(1ÀÏÂ÷) : 2024-06-20 0 0 2024-05-27
20828 ºÎ»ê ´ëÇѼҾÆû¼Ò³â°úÇÐȸ ºÎ»êÁöȸ Áý´ãȸ : 2024-06-20 0 3 2024-05-27
20827 ºÎ»ê ´ëÇѾȰúÇÐȸ ºÎ»êÁöȸ Á¦ 510ȸ ÇмúÁý´ãȸ : 2024-06-20 0 1 2024-05-27
20826 ºÎ»ê 2024³âµµ ºÎ»ê․°æ³²Áö¿ª ÀÇ°ú´ëÇÐ ½ÅÀÓ±³¼ö ¿öÅ©¼ó (1ÀÏÂ÷) : 2024-06-20 0 0 2024-05-27
20825 ¼­¿ï (¿Â¶óÀÎ) ´ëÇÑÅëÁõÇÐȸ ¼­¿ïÁöȸ Áý´ãȸ : 2024-06-20 0 0 2024-05-27
20824 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À°(¼­½Ä ÀÛ¼º ½ÇÁ¦) : 2024-06-20 0 0 2024-05-27
20823 °æ±â µ¿±¹´ëÇб³ Àϻ꺴¿ø : °ñ°üÀý¿°ÀÇ Áø´Ü ¹× Ä¡·á : 2024-06-19 0 1 2024-05-27
20822 °æ±â ´ëÇÑ°£ÇÐȸ Overlooked Liver Diseases : 2024-06-19 0 7 2024-05-27
20821 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦2ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-06-17 0 4 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷